Brucke Financial, Inc.

Position in ABBV — AbbVie Inc.

CIK 2058446 INDIANAPOLIS, IN

Position in ABBV

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$707,108

+$145,332 QoQ

Shares Held

2,810

+8.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.67%

of 13F equity value

Holder Rank

#2,866

of 4,153 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Brucke Financial, Inc. holds $4,830,124 across 6 Drug Manufacturers - General names. ABBV ranks #4 (14.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,197	$1,435,717
2	JNJ	Johnson & Johnson	4,299	$1,091,817
3	MRK	Merck & Co., Inc.	6,337	$814,304
4	ABBV	AbbVie Inc. This page	2,810	$707,108
5	NVS	Novartis AG	2,999	$470,003
6	GILD	Gilead Sciences, Inc.	2,463	$311,175

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$707,108	2,810	+8.8%	Shares	Sole	2026-07-21
2026-03-31	$561,776	2,583	+3.2%	Shares	Sole	2026-04-10
2025-12-31	$571,910	2,503	+4.3%	Shares	Sole	2026-01-12
2025-09-30	$555,696	2,400	-8.0%	Shares	Sole	2025-11-12
2025-06-30	$484,282	2,609	+1.4%	Shares	Sole	2025-07-24
2025-03-31	$539,094	2,573	+1.8%	Shares	Sole	2025-05-08
2024-12-31	$449,047	2,527	—	Shares	Sole	2025-02-27
No filing history on record for this holder in this stock.